CEA (carcinoembryonic antigen)-FC recombinant protein
- Catalog No.:YD3023
- Reactivity:Human;
- Purity:
- >90% as determined by SDS-PAGE
- Gene Name:
- CEACAM5
- Protein Name:
- Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)
- Sequence:
- Amino acid:35-314,with FC tag.
- Human Gene Id:
- 1048
- Human Swiss Prot No:
- P06731
- Formulation:
- Phosphate-buffered solution
- Source:
- Mammalian cells
- Storage Stability:
- -15°C to -25°C/1 year(Avoid freeze / thaw cycles)
- Other Name:
- Carcinoembryonic antigen-related cell adhesion molecule 5 ;Carcinoembryonic antigen;CEA;Meconium antigen 100;CD antigen CD66e;CEACAM5;CEA;
- Function:
- Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:10864933, PubMed:10910050, PubMed:2803308). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050).; (Microbial infection) Receptor for E.coli Dr adhesins. Binding of E.coli Dr adhesins leads to dissociation of the homodimer.
- Subcellular Location:
- Cell membrane ; Lipid-anchor, GPI-anchor . Apical cell membrane . Cell surface . Note=Localized to the apical glycocalyx surface. .
- Expression:
- Expressed in columnar epithelial and goblet cells of the colon (at protein level) (PubMed:10436421). Found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon.
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs